Press releases
Access archived Guidant press releases
Access archived BTG press releases
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Oct 13, 2008Joint efforts will focus on intravascular ultrasound (IVUS)
GE Healthcare (NYSE: GE) and intravascular ultrasound (IVUS) market leader Boston Scientific Corporation (NYSE: BSX) today...
-
Oct 13, 2008
Thursday and Friday of last week saw continued heavy trading in Boston Scientific's (NYSE: BSX) stock. As anticipated in the Company's October 9th...
-
Oct 12, 2008
Boston Scientific Corporation (NYSE: BSX) today announced results from an analysis of nearly 7,500 patients from its TAXUS ARRIVE 1...
-
Oct 12, 2008New coronary stent features thin struts designed for more uniform drug delivery
Boston Scientific Corporation (NYSE: BSX) today announced comprehensive data from the TAXUS ATLAS clinical program, a series of...
-
Oct 10, 2008
Boston Scientific Corporation (NYSE: BSX) today announced it has received approval from the U.S. Food and Drug Administration (FDA) to market its...
-
Oct 10, 2008
Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company's major events and press announcements at the Cardiovascular...
-
Oct 9, 2008
Yesterday saw heavy trading in Boston Scientific's (NYSE: BSX) stock, with approximately 38 million shares traded. This trading included involuntary...
-
Oct 8, 2008
Boston Scientific (NYSE: BSX) announced today it expects to record the following adjustments to its third quarter results, which it plans to report...
-
Oct 8, 2008PERSEUS clinical program to evaluate TAXUS® Element™ Platinum Chromium Stent
Boston Scientific Corporation (NYSE: BSX) today announced that it has completed enrollment in the PERSEUS trial, designed to evaluate the Company's...
-
Oct 1, 2008
Boston Scientific Corporation (NYSE: BSX) announced today that the United States District Court in Delaware has entered judgment against the Company...
-
Sep 25, 2008Company also announces FDA approval of TAXUS® Express2™ Stent System for treatment of in-stent restenosis
Boston Scientific Corporation (NYSE: BSX) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) to market...
-
Sep 19, 2008
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the UBS Global Life Sciences Conference, which is being held September 22...
-
Sep 15, 2008
Boston Scientific Corporation (NYSE: BSX) announced today a decision by the United States District Court in Delaware. The case involves a patent...
-
Sep 9, 2008
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Bank of America 38th Annual Investment Conference which is being held...
-
Sep 2, 2008
Boston Scientific Corporation (NYSE: BSX) today announced positive one-year results from the European and Intercontinental...
-
Sep 1, 2008
Boston Scientific Corporation (NYSE: BSX) today announced one-year data from its landmark SYNTAX trial comparing percutaneous...
-
Aug 29, 2008Boston Scientific obligation reduced from $250 to $19 million
Boston Scientific Corporation (NYSE: BSX) today announced that the U.S. District Court of Marshall, Texas found two patents of Medtronic, Inc....
-
Aug 26, 2008Company to present data from landmark SYNTAX clinical trial
Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company's major events and press announcements at the European...
-
Jul 21, 2008
Boston Scientific Corporation (NYSE: BSX) today announced financial results for the second quarter ended June 30, 2008, as well as guidance for net...
-
Jul 2, 2008Boston Scientific only company to offer choice of two distinct drugs on separate drug-eluting stent platforms
Boston Scientific Corporation (NYSE: BSX) today announced that the U.S. Food and Drug Administration (FDA) has approved the PROMUS™...
-
Jun 26, 2008
Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the second quarter ended June 30, 2008...
-
Jun 23, 2008
Boston Scientific Corporation (NYSE: BSX) today welcomed progress on a number of pieces of legislation that will help service veterans and the...
-
Jun 19, 2008Transactions further Company's plans to focus on core businesses and increase shareholder value
Boston Scientific Corporation - today announced that it has signed a definitive agreement to sell its investments in a portfolio of companies,...
-
Jun 9, 2008
Boston Scientific Corporation (NYSE: BSX) today welcomed an announcement by Fitch Ratings that it has revised its Rating Outlook on the Company, to...
-
Jun 5, 2008
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in Goldman Sachs' Annual Healthcare Conference, which is being held June 9-12...
-
Jun 3, 2008Company announces management changes and further organizational consolidation
Boston Scientific Corporation (NYSE: BSX) announced today that President and Chief Executive Officer Jim Tobin will be extending his tenure at the...
-
May 29, 2008Environmentally focused improvements are hallmark of renovations to Endosurgery headquarters
Boston Scientific Corporation (NYSE: BSX) today announced it has received Leadership in Energy and Environmental Design (LEED) certification from...
-
May 28, 2008
Boston Scientific Corporation (NYSE: BSX) and CryoCor, Inc. (NASDAQ: CRYO) today announced that Boston Scientific has completed its...
-
May 28, 2008
Boston Scientific Corporation (NYSE: BSX) today announced that a U.S. District Court jury in Marshall, Texas has reached a verdict in a patent...
-
May 20, 2008Positive results presented at Digestive Disease Week® 2008
Boston Scientific Corporation (NYSE: BSX) today announced results from an international, multi-center patient registry documenting...
-
May 19, 2008New size allows for treatment of smaller-diameter diseased saphenous vein grafts
Boston Scientific Corporation (NYSE: BSX) today announced the launch of its FilterWire EZ™ Embolic Protection System in a new 2.25 - 3.5 mm size,...
-
May 16, 2008ACUITY® Spiral lead has smallest left ventricular lead tip profile in the industry
Boston Scientific Corporation (NYSE: BSX) today announced U.S. Food and Drug Administration (FDA) approval of its ACUITY® Spiral left ventricular...
-
May 16, 2008Results of international, multi-center registry presented at conference
Boston Scientific Corporation (NYSE: BSX) today announced that results from an international, multi-center patient registry documenting the safety...
-
May 15, 2008ALTITUDE clinical science initiative will provide insights to ICD and CRT-D device therapy
Boston Scientific Corporation (NYSE: BSX) today announced a new clinical science initiative, ALTITUDE, which will analyze data(1) from the...
-
May 13, 2008COGNIS™ CRT-D and TELIGEN™ ICD represent entirely new platforms
Boston Scientific Corporation (NYSE: BSX) today announced U.S. Food and Drug Administration (FDA) approval of its COGNIS™ cardiac...
-
May 13, 2008
Boston Scientific Corporation (NYSE: BSX) today announced results from an analysis of nearly 7,500 patients from its TAXUS...
-
May 13, 2008
Boston Scientific Corporation (NYSE: BSX) today welcomed two-year results from the SPIRIT III clinical trial, which continue to...
-
May 13, 2008Company supports efforts of International Diabetes Federation to promote worldwide diabetes care and prevention
Boston Scientific Corporation (NYSE: BSX) and the International Diabetes Federation (IDF) today announced that Boston...
-
May 8, 2008
Boston Scientific Corporation (NYSE: BSX) announced today that the Canadian Federal Court has issued judgment in a lawsuit in which Johnson & Johnson...
-
May 8, 2008
Boston Scientific Corporation (NYSE: BSX) today announced U.S. Food and Drug Administration (FDA) approval of its ALTRUA™ family of pacemakers....
-
May 7, 2008Boston Scientific Announces European Approval and Market Launch of New Family of Advanced Pacemakers
Boston Scientific Corporation (NYSE: BSX) today announced CE Mark approval and market launch of its ALTRUA™ family of pacemakers. ALTRUA is Boston...
-
May 5, 2008
Boston Scientific Corporation (NYSE: BSX) announced today that a World Intellectual Property Organization (WIPO) arbitration panel has issued its...
-
Apr 30, 2008
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Deutsche Bank Health Care Conference, which is being held May 5-7 in...
-
Apr 24, 2008
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Morgan Stanley Global Healthcare Unplugged Conference, which is being...
-
Apr 24, 2008
Boston Scientific Corporation (NYSE: BSX) today announced completion of enrollment in the Multicenter Automatic Defibrillator Implantation Trial...
-
Apr 23, 2008
Boston Scientific Corporation (NYSE: BSX) today announced that it has been named U.S. Healthcare Supplier of the Year in the GHXcellence Awards...
-
Apr 21, 2008
Boston Scientific Corporation (NYSE: BSX) today announced financial results for the first quarter ended March 31, 2008, as well as guidance for...
-
Apr 17, 2008Company plans to launch product immediately
Boston Scientific Corporation (NYSE: BSX) today announced that it has received approval for the sale of its TAXUS® Liberte® paclitaxel-eluting...
-
Apr 16, 2008
Boston Scientific Corporation (NYSE: BSX) and CryoCor, Inc. (NASDAQ: CRYO) today announced the signing of a definitive...
-
Apr 15, 2008Emerging technology will potentially enable access to MRI exams for implantable cardiac device patients
Boston Scientific Corporation (NYSE: BSX) and Surgi-Vision, Inc., a privately held company, today announced a licensing and...
-
Apr 14, 2008ACUITY® Steerable lead also receives reimbursement approval; Company plans to launch product immediately
Boston Scientific Corporation (NYSE: BSX) today announced Japanese Ministry of Health, Labor and Welfare (MHLW) approval of its ACUITY® Steerable...
-
Apr 7, 2008
Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the first quarter ended March 31,...
-
Apr 7, 2008
Boston Scientific Corporation (NYSE: BSX) today announced the appointment of Timothy Pratt as its new General Counsel. Pratt is a nationally...
-
Apr 2, 2008Judgment entered in favor of Guidant and its former directors/officers
Boston Scientific Corporation (NYSE: BSX) today announced that United States District Judge Sarah Evans Barker, Indianapolis, dismissed...
-
Apr 1, 2008
Boston Scientific Corporation (NYSE: BSX) today announced results from a pooled analysis of patients from its TAXUS IV and TAXUS...
-
Apr 1, 2008Results from TAXUS IV and V randomized clinical trials favor DES compared to bare-metal stents
Boston Scientific Corporation (NYSE: BSX) today welcomed favorable outcomes of one- year data from the Company's TAXUS IV and V...
-
Mar 31, 2008At two years, Company's TAXUS® and PROMUS™ Stents demonstrate positive and similar outcomes
Boston Scientific Corporation (NYSE: BSX) today welcomed positive two-year results from Abbott's prospective, randomized (3:1), single...
-
Mar 31, 2008
Boston Scientific Corporation (NYSE: BSX) today announced the sale of Boston Scientific Santa Rosa Corp., formerly known as TriVascular, Inc., to...
-
Mar 29, 2008
Boston Scientific Corporation (NYSE: BSX) today announced results from an analysis of two-year data from more than 7,000 patients in...
-
Mar 29, 2008
Boston Scientific Corporation (NYSE: BSX) today announced results from an analysis of 4,772 patients from its TAXUS ARRIVE 1 and 2...
-
Mar 25, 2008
Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company's major events and news announcements at the Society for...
-
Mar 11, 2008
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Lehman Brothers Health Care Conference, which is being held March 18...
-
Mar 3, 2008ACUITY® Spiral lead offers flexibility for placement in small, medium and large veins
Boston Scientific Corporation (NYSE: BSX) today announced CE Mark approval of its ACUITY® Spiral left ventricular lead for use with cardiac...
-
Feb 28, 2008
Boston Scientific Corporation (NYSE: BSX) today announced the first European implants of its COGNIS™ cardiac resynchronization therapy...
-
Feb 26, 2008Dr. Jay Schnitzer to join the Company
Boston Scientific Corporation (NYSE: BSX) today announced that Jay J. Schnitzer, M.D., Ph.D. will be joining the Company's Clinical Sciences...
-
Feb 25, 2008Approvals include CONFIENT™ ICD, LIVIAN™ CRT-D and upgraded LATITUDE® Patient Management System
Boston Scientific Corporation (NYSE: BSX) today announced U.S. Food and Drug Administration (FDA) approval for three products in its Cardiac Rhythm...
-
Feb 14, 2008
Boston Scientific Corporation (NYSE: BSX) today announced that it has completed the sale of its Fluid Management and Venous Access businesses to...
-
Feb 12, 2008
Boston Scientific Corporation (NYSE: BSX) today announced that a U.S. District Court jury in Marshall, Texas has reached a verdict in a patent...
-
Feb 11, 2008PROENCY will provide real-world clinical data on the PROMUS™ Stent
Boston Scientific Corporation (NYSE: BSX) today announced that the first patient has been enrolled in its PROENCY (PROMUS™, ENdeavor® and...
-
Feb 4, 2008
Boston Scientific Corporation (NYSE: BSX) today announced financial results for the fourth quarter and full year ended December 31, 2007, as well as...
-
Feb 4, 2008'Close the Gap' brings together advocates from cardiologists to coaches
Boston Scientific Corporation (NYSE: BSX) today announced the public debut of an educational initiative called "Close the Gap," which is aimed at...
-
Jan 30, 2008
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical...
-
Jan 23, 2008
Boston Scientific (NYSE: BSX) today issued the following statement from Donald S. Baim, M.D., Chief Medical and Scientific Officer, on an article in the New...
-
Jan 23, 2008
Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the fourth quarter and the year ended...
-
Jan 22, 2008
Boston Scientific Corporation (NYSE: BSX) today announced CE Mark approval for its COGNIS™ cardiac resynchronization therapy defibrillator...
-
Jan 7, 2008
Boston Scientific Corporation (NYSE: BSX) today announced that the Court of Appeals for the Federal Circuit affirmed a District Court ruling which...
-
Jan 7, 2008
Boston Scientific Corporation (NYSE: BSX) today announced that it has completed the sale of its Cardiac Surgery and Vascular Surgery businesses to...
-
Jan 4, 2008Company retains ownership of Pain Management business
Boston Scientific Corporation (NYSE: BSX) today announced that it has completed the sale of the controlling interests in its auditory business and...
-
Jan 3, 2008
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the upcoming JP Morgan Health Care Conference, in San Francisco. Paul...
-
Dec 28, 2007
Boston Scientific Corporation (NYSE: BSX) today announced CE Mark approval for its LIVIAN™ cardiac resynchronization therapy defibrillator...
-
Dec 21, 2007TAXUS Liberte has more CE Mark-approved indications than any other drug-eluting stent
Boston Scientific Corporation (NYSE: BSX) announced today that its TAXUS® Liberte™ paclitaxel-eluting coronary stent system has received...
-
Dec 13, 2007
Boston Scientific Corporation (NYSE: BSX) and Avista Capital Partners, a leading private equity firm, today jointly announced the...
-
Nov 29, 2007
Boston Scientific Corporation (NYSE: BSX) today welcomed the recommendation of a U.S. Food and Drug Administration (FDA) advisory panel to approve...
-
Nov 28, 2007
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the BMO Capital Markets Healthcare Conference, which is being held...
-
Nov 21, 2007
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Piper Jaffray Health Care Conference, which is being held November 27...
-
Nov 19, 2007
Boston Scientific Corporation (NYSE: BSX) today announced that an amended agreement has been reached to settle claims associated with a series of...
-
Nov 6, 2007
Boston Scientific Corporation (NYSE: BSX) and GE Healthcare (NYSE: GE) today announced the industry's first patient data...
-
Nov 5, 2007
Boston Scientific Corporation (NYSE: BSX) today announced the signing of a definitive agreement for the sale of its Cardiac Surgery and Vascular...
-
Oct 31, 2007
Boston Scientific Corporation (NYSE: BSX) announced today that a jury in U.S. District Court in San Francisco has found that Boston Scientific...
-
Oct 26, 2007Dr. Keith Dawkins and Dr. Takahiro Uchida to join the Company
Boston Scientific today announced that Keith Dawkins, M.D., and Takahiro Uchida, M.D., will be joining the Company's Clinical Sciences...
-
Oct 23, 2007
Boston Scientific Corporation (NYSE: BSX) today announced positive three-year results from its CABERNET and BEACH carotid artery...
-
Oct 22, 2007TAXUS IV study demonstrates long-term safety and efficacy of TAXUS drug- eluting stent compared to bare-metal stent
Boston Scientific Corporation (NYSE: BSX) today announced five-year and final follow- up data from its TAXUS IV clinical trial. The...
-
Oct 22, 2007TAXUS ATLAS studies also reinforce deliverability of TAXUS® Liberte® drug-eluting stent in long lesions and small vessels
Boston Scientific Corporation (NYSE: BSX) today announced nine-month data from the pivotal TAXUS ATLAS Small Vessel and Long Lesion...
-
Oct 22, 2007
Boston Scientific Corporation (NYSE: BSX) today welcomed results from the SPIRIT III Clinical Trial, which continue to support the...
-
Oct 21, 2007
Boston Scientific Corporation (NYSE: BSX) today announced results from an analysis of nearly 7,000 patients from its TAXUS ARRIVE 1...
-
Oct 19, 2007
Boston Scientific Corporation (NYSE: BSX) today announced financial results for the third quarter ended September 30, 2007, as well as guidance for...
-
Oct 17, 2007Approximately 2,300 positions to be eliminated worldwide
Boston Scientific Corporation (NYSE: BSX) today announced several new initiatives designed to enhance short- and long-term shareholder value,...
-
Oct 16, 2007
Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company's major events and press announcements at the Cardiovascular...
-
Oct 9, 2007
Boston Scientific Corporation (NYSE: BSX) today announced CE Mark approval of its CONFIENT™ implantable cardioverter defibrillator (ICD). This...
-
Oct 1, 2007
Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the third quarter ended September 30,...